$377,375,000 in Total Settlement Funds Available. See if you qualify!Find Out More

Levi & Korsinsky Appointed as Counsel in Intellia Case

News Page

Published June 5, 2025

Gonzalez v. Intellia Therapeutics, Inc., et al., case no. 1:25-cv-10353-DJC, is a securities fraud lawsuit currently pending before Judge Denise J. Casper in the U.S. District Court for the District of Massachusetts. The complaint alleges that Intellia misled investors about the viability of its gene-editing therapy, NTLA-3001, and that when the truth came out, the company’s stock price fell sharply, resulting in significant investor losses.

On May 26, 2025, Judge Casper appointed John D. Albaugh, James Scott Ewert, Yiu Chung Lee, and Ronnie Evans as co-lead plaintiffs. In the same order, the Court appointed Levi & Korsinsky, LLP and Pomerantz LLP as co-lead counsel.

A copy of the order can be found here.